Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Gross Margin: 2017-2018

Historic Gross Margin for Astria Therapeutics (ATXS) over the last 2 years, with Sep 2018 value amounting to 100.00%.

  • Astria Therapeutics' Gross Margin changed negligibly% to 100.00% in Q3 2018 from the same period last year, while for Sep 2018 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2018, which is negligibly% changed negligibly from last year.
  • As of Q3 2018, Astria Therapeutics' Gross Margin stood at 100.00%, which was down 0.00% from 100.00% recorded in Q2 2018.
  • In the past 5 years, Astria Therapeutics' Gross Margin ranged from a high of 100.00% in Q1 2017 and a low of 100.00% during Q1 2017.
  • In the last 2 years, Astria Therapeutics' Gross Margin had a median value of 100.00% in 2018 and averaged 100.00%.